Clinical Trials Directory

Trials / Completed

CompletedNCT07446933

Vasopressin vs. Uterine Artery Clamping for Laparoscopic Cesarean Scar Niche Repair

Noninferiority of Intramyometrial Vasopressin Injection Compared to Bilateral Temporary Clamping of Uterine Arteries During Laparoscopic Excision and Repair of Cesarean Scar Niche

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Zagazig University · Other Government
Sex
Female
Age
21 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study evaluates two methods for controlling intraoperative bleeding during laparoscopic surgery to repair a cesarean scar niche (CSN). It compares the effectiveness of intramyometrial vasopressin injection against bilateral temporary clamping of the uterine arteries using laparoscopic bulldog clips. The goal is to determine if vasopressin injection is non-inferior to arterial clamping in reducing blood loss and maintaining surgical field visibility.

Conditions

Interventions

TypeNameDescription
DRUGVasopressin GroupPatients receive a local injection of 12 mL of diluted vasopressin into the myometrium directly surrounding the cesarean scar niche. This is performed during the laparoscopic procedure, just before the excision of the fibrous scar tissue, to constrict local blood vessels and minimize intraoperative bleeding.
PROCEDUREBulldog Clamping GroupThis intervention involves the temporary mechanical clamping of both uterine arteries using laparoscopic bulldog vascular clips. The clips are applied to block blood flow to the uterus before the niche is excised and are removed once the myometrial reconstruction is complete.
PROCEDUREStandard of CareApproach: A 3-port laparoscopic approach using Storz endoscopic instruments. Excision: Complete removal of the fibrous scar tissue surrounding the niche defect. Reconstruction: Suturing and repair of the myometrium to resolve the defect.

Timeline

Start date
2024-03-20
Primary completion
2025-10-17
Completion
2026-01-15
First posted
2026-03-03
Last updated
2026-03-03

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT07446933. Inclusion in this directory is not an endorsement.